{"id":{"repo_id":"calgary","oai_identifier":"oai:ucalgary.scholaris.ca:11023/3941"},"canonical_url":"https://search.dev.ndltd.org/etd/calgary/oai:ucalgary.scholaris.ca:11023/3941","repository":{"repo_id":"calgary","name":"University of Calgary","base_url":"https://ucalgary.scholaris.ca/server/oai/request"},"display":{"title":"The Immune Modulatory Effects of Tylvalosin in Porcine Neutrophils and Macrophages in vitro","abstract":"Tylavlosin (TYL), a veterinary macrolide antibiotic, has been reported to have superior efficacy treating bacterial infections of the respiratory tract in swine. This study aims to characterize potential pro-resolving of tylvalosin benefits in a porcine model by elucidating its effects, in isolated neutrophils and monocyte-derived macrophages from piglets. Our findings indicate that TYL increases porcine neutrophil and macrophage apoptosis in a dose-dependent and time-dependent manners, without affecting levels of necrosis. TYL also modulates mediators of inflammation, by increasing pro-resolving lipid mediators (LXA4 and RvD1) in neutrophils and down regulating the pro- inflammatory mediators in stimulated neutrophils (LTB4) and in stimulated macrophages (CXCL8 and IL-1α). Together, these findings demonstrate that tylvalosin has immuno- modulating properties in vitro, including the induction of leukocyte apoptosis, the inhibition of pro-inflammatory cytokines and lipids mediators, and the induction of pro- resolving lipid mediators. Future studies using live piglets will help determine whether and how these effects may translate into anti-inflammatory benefits in the content of inflammatory disease within the lung.","abstract_html":"Tylavlosin (TYL), a veterinary macrolide antibiotic, has been reported to have superior efficacy treating bacterial infections of the respiratory tract in swine. This study aims to characterize potential pro-resolving of tylvalosin benefits in a porcine model by elucidating its effects, in isolated neutrophils and monocyte-derived macrophages from piglets. Our findings indicate that TYL increases porcine neutrophil and macrophage apoptosis in a dose-dependent and time-dependent manners, without affecting levels of necrosis. TYL also modulates mediators of inflammation, by increasing pro-resolving lipid mediators (LXA4 and RvD1) in neutrophils and down regulating the pro- inflammatory mediators in stimulated neutrophils (LTB4) and in stimulated macrophages (CXCL8 and IL-1α). Together, these findings demonstrate that tylvalosin has immuno- modulating properties in vitro, including the induction of leukocyte apoptosis, the inhibition of pro-inflammatory cytokines and lipids mediators, and the induction of pro- resolving lipid mediators. Future studies using live piglets will help determine whether and how these effects may translate into anti-inflammatory benefits in the content of inflammatory disease within the lung.","abstract_has_math":false,"creators":["Moges, Ruth"],"institution":"Graduate Studies","degree_name":"Master of Science (MSc)","degree_level":null,"degree_discipline":"Biological Sciences","degree_department":null,"school":null,"contributors":[],"advisors":["Buret, Andre"],"committee_chairs":[],"committee_members":["Morck, Douglas","Storey, Douglas"],"year":2017,"date_issued":"2017","date_published":"2017","updated_at":"2026-07-24T01:30:31Z","subjects":["Microbiology"],"languages":["eng"],"rights":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.doi","label":"DOI","values":["http://dx.doi.org/10.11575/PRISM/28175"],"render_values":[{"text":"http://dx.doi.org/10.11575/PRISM/28175","href":"http://dx.doi.org/10.11575/PRISM/28175","code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/11023/3941","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Buret, Andre"]},{"key":"dc:contributor.committeemember","label":"Committee Member","values":["Morck, Douglas","Storey, Douglas"]},{"key":"dc:creator","label":"Author","values":["Moges, Ruth"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2017-07-11T15:27:50Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2017-07-11T15:27:50Z"]},{"key":"dc:date.issued","label":"Date","values":["2017"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Calgary"]},{"key":"dc:type","label":"Dc Type","values":["master thesis"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Biological Sciences"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Master of Science (MSc)"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Calgary"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Microbiology"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.doi","label":"DOI","values":["http://dx.doi.org/10.11575/PRISM/28175"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/11023/3941"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Tylavlosin (TYL), a veterinary macrolide antibiotic, has been reported to have superior efficacy treating bacterial infections of the respiratory tract in swine. This study aims to characterize potential pro-resolving of tylvalosin benefits in a porcine model by elucidating its effects, in isolated neutrophils and monocyte-derived macrophages from piglets. Our findings indicate that TYL increases porcine neutrophil and macrophage apoptosis in a dose-dependent and time-dependent manners, without affecting levels of necrosis. TYL also modulates mediators of inflammation, by increasing pro-resolving lipid mediators (LXA4 and RvD1) in neutrophils and down regulating the pro- inflammatory mediators in stimulated neutrophils (LTB4) and in stimulated macrophages (CXCL8 and IL-1α). Together, these findings demonstrate that tylvalosin has immuno- modulating properties in vitro, including the induction of leukocyte apoptosis, the inhibition of pro-inflammatory cytokines and lipids mediators, and the induction of pro- resolving lipid mediators. Future studies using live piglets will help determine whether and how these effects may translate into anti-inflammatory benefits in the content of inflammatory disease within the lung."]},{"key":"dc:title","label":"Title","values":["The Immune Modulatory Effects of Tylvalosin in Porcine Neutrophils and Macrophages in vitro"]}]}],"canonical_facts":{"dc:contributor.advisor":["Buret, Andre"],"dc:contributor.committeemember":["Morck, Douglas","Storey, Douglas"],"dc:creator":["Moges, Ruth"],"dc:date.accessioned":["2017-07-11T15:27:50Z"],"dc:date.available":["2017-07-11T15:27:50Z"],"dc:date.issued":["2017"],"dc:description.abstract":["Tylavlosin (TYL), a veterinary macrolide antibiotic, has been reported to have superior efficacy treating bacterial infections of the respiratory tract in swine. This study aims to characterize potential pro-resolving of tylvalosin benefits in a porcine model by elucidating its effects, in isolated neutrophils and monocyte-derived macrophages from piglets. Our findings indicate that TYL increases porcine neutrophil and macrophage apoptosis in a dose-dependent and time-dependent manners, without affecting levels of necrosis. TYL also modulates mediators of inflammation, by increasing pro-resolving lipid mediators (LXA4 and RvD1) in neutrophils and down regulating the pro- inflammatory mediators in stimulated neutrophils (LTB4) and in stimulated macrophages (CXCL8 and IL-1α). Together, these findings demonstrate that tylvalosin has immuno- modulating properties in vitro, including the induction of leukocyte apoptosis, the inhibition of pro-inflammatory cytokines and lipids mediators, and the induction of pro- resolving lipid mediators. Future studies using live piglets will help determine whether and how these effects may translate into anti-inflammatory benefits in the content of inflammatory disease within the lung."],"dc:identifier.doi":["http://dx.doi.org/10.11575/PRISM/28175"],"dc:identifier.uri":["http://hdl.handle.net/11023/3941"],"dc:language.iso":["eng"],"dc:publisher.institution":["University of Calgary"],"dc:rights":["University of Calgary graduate students retain copyright ownership and moral rights for their thesis. You may use this material in any way that is permitted by the Copyright Act or through licensing that has been assigned to the document. For uses that are not allowable under copyright legislation or licensing, you are required to seek permission."],"dc:subject":["Microbiology"],"dc:title":["The Immune Modulatory Effects of Tylvalosin in Porcine Neutrophils and Macrophages in vitro"],"dc:type":["master thesis"],"thesis:degree_discipline":["Biological Sciences"],"thesis:degree_name":["Master of Science (MSc)"],"thesis:institution_name":["University of Calgary"]},"updated_at":"2026-07-24T01:30:31Z"}